Atrogi AB
- Address
- Tomtebodavagen 6
Sponsor Overview
assignment
1
sponsored trial
science
0
molecules
location_city
1
research centre
public
1
country
person_search
1
investigator
Specializations
Type 2 diabetes
Atrogi AB’s clinical research is centred on type 2 diabetes, with interest in therapies that address metabolic control and the management of glycaemic regulation.
- Type 2 diabetes treatment
- Metabolic disease
- Blood glucose control
The sponsor’s research activity reflects a focus on endocrinology and diabetes therapeutics, particularly oral treatment approaches relevant to chronic metabolic disease.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Pharmacokinetic Assessment of ATR-258 Oral Capsule Versus Solution in Type 2 Diabetes: A Randomized, Open-Label, Cross-Over Study |  Sweden | Not Recruiting |
Data & Insights
science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 0 total (0% not shared with other sponsors)
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 1 sites collaborated multiple times
This sponsor has worked with 1 site across their trial portfolio.
Therapeutic Focus
- 1.Nutritional and Metabolic Diseases1 trial211 other sponsors
Partnered Research Centres
1 centrelocation_city
assignment66CTC Clinical Trial Consultants AB
- Address
- Dag Hammarskjolds Vag 10b, Uppsala Domkyrkofors., 752 37 Uppsala
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Atrogi AB.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.